Novavax Inc
Company Profile
Business description
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
Contact
700 Quince Orchard Road
Gaithersburg MD 20878
USAT: +1 240 268-2000
E: ir@novavax.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
1,992
Novavax Inc News & Analysis
stocks
Vaccine rollout and herd immunity to end the pandemic
markets
What a Covid-19 vaccine means for investors
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,932.00 | 25.40 | 0.32% |
| CAC 40 | 8,065.15 | 23.09 | -0.29% |
| DAX 40 | 18,118.32 | 42.69 | -0.24% |
| Dow JONES (US) | 38,386.09 | 146.43 | 0.38% |
| FTSE 100 | 8,147.03 | 7.20 | 0.09% |
| HKSE | 17,757.54 | 10.63 | 0.06% |
| NASDAQ | 15,983.08 | 55.18 | 0.35% |
| Nikkei 225 | 38,405.66 | 470.90 | 1.24% |
| NZX 50 Index | 11,957.50 | 41.26 | 0.35% |
| S&P 500 | 5,116.17 | 16.21 | 0.32% |
| S&P/ASX 200 | 7,664.10 | 26.70 | 0.35% |
| SSE Composite Index | 3,109.95 | 3.10 | -0.10% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Worley Ltd WOR | 15.09 | 1.22 | -7.48% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 3.03% |
| Tietto Minerals Ltd TIE | 0.68 | 0.00 | 0.00% |
| Pilbara Minerals Ltd PLS | 4.06 | 0.10 | 2.53% |
| Mesoblast Ltd MSB | 0.99 | 0.10 | -8.76% |
| South32 Ltd S32 | 3.59 | 0.08 | 2.28% |
| Imugene Ltd IMU | 0.09 | 0.01 | 6.10% |
| Telstra Group Ltd TLS | 3.67 | 0.01 | 0.27% |
| Core Lithium Ltd CXO | 0.15 | 0.01 | 3.57% |
| Liontown Resources Ltd LTR | 1.25 | 0.04 | 2.89% |